Dr. Rajiv Lal, MD

Dr. Lal practices at West Houston Plastic Surgery Center PLLC in Houston, Texas.

Dr. Lal's NPI, 1194757534, was assigned on July 7, 2006. Dr. Lal graduated from All India Institute of Medical Sciences in 2000. Dr. Lal holds Texas license M3288.

Dr. Lal's primary practice is West Houston Plastic Surgery Center PLLC, at 915 Gessner Rd, Houston, TX 77024 in Harris County. The practice phone is (713) 468-5200.

Dr. Lal's primary practice is West Houston Plastic Surgery Center PLLC in Houston, Texas. Dr. Lal is also affiliated with Memorial Hermann-Texas Medical Center. The medical group on file is Renal Clinic of Houston. Dmand AI also links Dr. Lal to 4 more hospitals, 5 dialysis centers and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lal practices, 11 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Lal's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Lal is board certified in nephrology by the American Board of Internal Medicine. Dr. Lal is licensed in Texas.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances, hypercalcemia, kidney cysts and kidney disease among the conditions Dr. Lal treats.

CMS data shows 2,560 Medicare services from Dr. Lal across 11 procedure codes in 2024, for 471 Medicare patients. Medicare paid $150,226 for them.

CMS counts 471 Medicare patients who saw Dr. Lal in 2024. The largest group is 75 to 84, with 172 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 10% are also on Medicaid. Their average risk score is 2.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lal's median patient age at 72, with 46% women.

In 2024, Dr. Lal wrote 1,473 Medicare Part D claims for 272 patients. 69% of them were for generic drugs. CMS names the drug for 1,248 of them, across 28 drugs with 11 or more claims each, at $299,278 in total drug cost. In 2023, CMS named 1,259 claims across 32 drugs.

Dr. Lal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lal as offering telehealth.

Dmand AI links 4 papers to Dr. Lal, published from 2006 to 2024. The most frequent topics are Drug Overdose. Dr. Lal has published most often in Ann Pharmacother. Dr. Lal's most frequent co-authors are Kevin W. Finkel, MD, John R. Foringer, MD and Ruchdi Barakat, MD.

CMS Open Payments shows 368 general payments to Dr. Lal from 38 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Relypsa, Inc. paid the most, $1,357.

Dmand AI lists 6 awards for Dr. Lal, most recently Chief of Medicine in 2024.

Dr. Lal graduated from All India Institute of Medical Sciences in 2000.

Dr. Lal is in network with 23 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 15. Check the plan with the practice before a visit.